CRISM: British Columbia Node


The BC Node of CRISM is an interdisciplinary expert network of over 50 contributing members, including advocacy groups, policy makers, service providers, and research scientists. The network is affiliated with the BC Centre on Substance Use, the University of British Columbia, and Simon Fraser University, among others. Through the translation of scientific evidence into practice and policy change, the network promotes evidence-based approaches to addiction treatment and provides training to the next generation of leaders through our comprehensive education programs. The group leading the BC CRISM Node has a long history of integrated research, education, and knowledge translation in addiction medicine, notably hosting North America's largest addiction medicine training program. As well, to ensure that research priorities align with lived experience of those affected by substance use disorders, we have well-established partnerships with community and advocacy groups, including the BC Association of People on Methadone (BCAPOM), the Vancouver Area Network of Drug Users (VANDU), the Western Aboriginal Harm Reduction Society (WAHRS), From Grief to Action (FGTA), and Moms Stop the Harm. Our linkages to treatment providers, health system administrators and government policy-makers, our training infrastructure, and our national and international collaborations ideally position us to undertake collaborative research and implementation of evidence-based therapeutic approaches.

Nominated Principal Investigator

Evan Wood, MD, PhD, FRCPC MD, PhD, ABIM, FRCPC, ABAM Diplomate; Professor of Medicine, UBC; Director, British Columbia Centre on Substance Use

Evan Wood is the Director of the British Columbia Centre on Substance Use based at St. Paul’s Hospital in Vancouver. He is also a professor of medicine at the University of British Columbia, where he helps lead the university’s efforts in the area of addiction prevention and treatment through a Tier 1 Canada Research Chair. Dr. Wood is a general internal medicine specialist and diplomate of the American Board of Addiction Medicine whose clinical, research and educational focus has been on improving systems of care for patients with alcohol and drug addiction. He has been the Physician Program Director for Addiction Services at Providence Health Care, Medical Director for Addiction Services at Vancouver Coastal Health and Founding Director of the St. Paul’s Hospital Goldcorp Fellowship in Addiction Medicine, Western Canada’s only American Board of Addiction Medicine accredited training program for addiction medicine physicians. He was also the founding Director of the Canada Addiction Medicine Research Fellowship, a US National Institute on Drug Abuse funded research-training program for physicians with a background in addiction medicine based out of UBC and St. Paul’s.

Principal Investigators


We seek to fulfill the following objectives:

  1. To engage with provincial stakeholders, including researchers, service providers and the affected community in BC, to establish a collaborative team of addiction researchers, service providers and affected community members positioned to establish a network and undertake addiction clinical trials as part of CRISM;
  2. To work with provincial, municipal, and Aboriginal government stakeholders to identify regional health system policy priorities for clinical research opportunities and seek optimal alignment between scientific objectives with health policy directions;
  3. To conduct pilot research aimed at consolidating governance and function, while establishing information technology and other requirements for conducting multi-site clinical trials; and
  4. To work with the CRISM teams in the Prairie provinces, Ontario and Quebec to establish the priorities of the national CRISM network

Contact information

Node Manager:
Shirley Wong, PhD
Tel: 604-360-1892

400-1045 Howe St. 
Vancouver, BC
V6Z 2A9

Date modified: